Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.
Biomarkers, Tumor
/ genetics
Breast Neoplasms
/ genetics
Databases, Genetic
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Humans
Immune Checkpoint Proteins
/ genetics
Immunological Synapses
/ genetics
MicroRNAs
/ genetics
Models, Genetic
RNA, Messenger
/ genetics
RNA, Neoplasm
/ genetics
Urinary Bladder Neoplasms
/ genetics
bladder cancer
immune checkpoints
immunological synapse
miRNA
microRNA
noncoding RNAs
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Mar 2021
04 Mar 2021
Historique:
received:
26
01
2021
revised:
21
02
2021
accepted:
23
02
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
27
4
2021
Statut:
epublish
Résumé
Personalised medicine is the future and hope for many patients, including those with cancers. Early detection, as well as rapid, well-selected treatment, are key factors leading to a good prognosis. MicroRNA mediated gene regulation is a promising area of development for new diagnostic and therapeutic methods, crucial for better prospects for patients. Bladder cancer is a frequent neoplasm, with high lethality and lacking modern, advanced therapeutic modalities, such as immunotherapy. MicroRNAs are involved in bladder cancer pathogenesis, proliferation, control and response to treatment, which we summarise in this perspective in response to lack of recent review publications in this field. We further performed a correlation-based analysis of microRNA and gene expression data in bladder cancer (BLCA) TCGA dataset. We identified 27 microRNAs hits with opposite expression profiles to genes involved in immune response in bladder cancer, and 24 microRNAs hits with similar expression profiles. We discuss previous studies linking the functions of these microRNAs to bladder cancer and assess if they are good candidates for personalised medicine therapeutics and diagnostics. The discussed functions include regulation of gene expression, interplay with transcription factors, response to treatment, apoptosis, cell proliferation and angiogenesis, initiation and development of cancer, genome instability and tumour-associated inflammatory reaction.
Identifiants
pubmed: 33806327
pii: ijms22052553
doi: 10.3390/ijms22052553
pmc: PMC7961343
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Immune Checkpoint Proteins
0
MicroRNAs
0
RNA, Messenger
0
RNA, Neoplasm
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Physiol Renal Physiol. 2018 May 1;314(5):F893-F905
pubmed: 29357417
Sci Rep. 2020 May 4;10(1):7484
pubmed: 32366870
Gastroenterol Res Pract. 2020 Aug 13;2020:4159298
pubmed: 32855634
Biosci Rep. 2019 Oct 30;39(10):
pubmed: 31652456
Lung Cancer. 2016 Sep;99:79-87
pubmed: 27565919
Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8657-8663
pubmed: 30575906
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9
pubmed: 16166262
EBioMedicine. 2019 Jun;44:439-451
pubmed: 31130475
Cancers (Basel). 2020 Oct 26;12(11):
pubmed: 33114775
Oncogene. 2013 Sep 26;32(39):4694-701
pubmed: 23085757
Onco Targets Ther. 2016 Mar 29;9:1813-22
pubmed: 27099514
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32571994
Sci Rep. 2019 Nov 8;9(1):16385
pubmed: 31705138
BMC Cancer. 2011 Apr 14;11:135
pubmed: 21489314
Pathol Res Pract. 2019 Nov;215(11):152598
pubmed: 31562019
Med Sci Monit. 2020 Apr 09;26:e923491
pubmed: 32269209
Kaohsiung J Med Sci. 2020 Oct;36(10):799-807
pubmed: 32558345
J Cell Mol Med. 2018 Mar;22(3):2033-2038
pubmed: 29363887
Mol Cell Probes. 2020 Aug;52:101562
pubmed: 32194149
Am J Cancer Res. 2013 Aug 14;3(4):356-73
pubmed: 23977446
Biomedicines. 2020 Oct 22;8(11):
pubmed: 33105660
J Exp Clin Cancer Res. 2018 Oct 20;37(1):257
pubmed: 30342533
Mol Med Rep. 2017 Dec;16(6):8709-8720
pubmed: 28990088
Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4828-4836
pubmed: 30070321
Cell Death Dis. 2020 Dec 14;11(12):1065
pubmed: 33311442
Oncol Lett. 2018 Mar;15(3):3814-3819
pubmed: 29467898
Sci Rep. 2019 Dec 11;9(1):18844
pubmed: 31827114
J Biochem. 2020 Jul 1;168(1):7-14
pubmed: 32003827
Biosci Rep. 2020 Jul 31;40(7):
pubmed: 32364222
Oncotarget. 2018 May 11;9(36):24457-24469
pubmed: 29849953
Sci Rep. 2020 May 19;10(1):8271
pubmed: 32427870
Med Sci Monit. 2014 Oct 07;20:1850-7
pubmed: 25287716
Cancer Manag Res. 2020 Sep 24;12:8951-8964
pubmed: 33061591
Sci Rep. 2019 Sep 25;9(1):13830
pubmed: 31554904
J Cell Biochem. 2018 Sep;119(9):7807-7817
pubmed: 29923283
Mol Med Rep. 2021 Jan;23(1):
pubmed: 33200802
Development. 2015 Sep 15;142(18):3210-21
pubmed: 26395145
J Cell Physiol. 2019 Mar;234(3):2905-2915
pubmed: 30145827
Urol Oncol. 2019 Dec;37(12):955-963
pubmed: 31635993
Int J Oncol. 2012 Jun;40(6):2097-103
pubmed: 22426940
Oncol Lett. 2018 Jul;16(1):815-820
pubmed: 29963149
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Oncotarget. 2018 Feb 12;9(19):14895-14908
pubmed: 29599914
Oncogene. 2020 Feb;39(9):1983-1996
pubmed: 31772330
J Recept Signal Transduct Res. 2022 Apr;42(2):133-140
pubmed: 33356743
Clin Genitourin Cancer. 2016 Oct;14(5):e493-e499
pubmed: 27157639
Cancer Cell Int. 2015 Nov 14;15:107
pubmed: 26582573
Int J Mol Sci. 2020 May 27;21(11):
pubmed: 32471285
J Cell Biochem. 2018 Dec;119(12):10005-10012
pubmed: 30171714
Urol Oncol. 2019 Feb;37(2):150-157
pubmed: 30455080
Gene. 2021 Jan 30;767:145079
pubmed: 32860901
Aging (Albany NY). 2021 Jan 20;13(3):4258-4273
pubmed: 33493140
Br J Cancer. 2013 Nov 26;109(11):2853-63
pubmed: 24169356
Cancer Biol Ther. 2020 Dec 1;21(12):1163-1170
pubmed: 33218285
Med Oncol. 2014 Jul;31(7):65
pubmed: 24952510
Acta Pharmacol Sin. 2017 Aug;38(8):1161-1170
pubmed: 28603285
Gut. 2017 Jan;66(1):124-136
pubmed: 27402485
Sci Rep. 2020 Dec 3;10(1):21112
pubmed: 33273694
Mol Cell Biochem. 2021 Mar;476(3):1575-1588
pubmed: 33400022
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9427-9435
pubmed: 31773681
Open Life Sci. 2020 Jun 11;15(1):389-399
pubmed: 33817227
Nat Rev Cancer. 2006 Apr;6(4):259-69
pubmed: 16557279
Int J Oncol. 2019 Jun;54(6):2222-2236
pubmed: 30942440
Cancer Med. 2019 May;8(5):2553-2560
pubmed: 30848099
Mol Ther Nucleic Acids. 2020 Jun 5;20:468-479
pubmed: 32278306
Oncotarget. 2015 Oct 6;6(30):29129-42
pubmed: 26320176
Neoplasma. 2020 Mar;67(2):215-228
pubmed: 31884798
Cancers (Basel). 2020 Dec 18;12(12):
pubmed: 33352935
Dig Liver Dis. 2019 Oct;51(10):1446-1455
pubmed: 31147216
Cancer Res. 2012 Nov 15;72(22):5945-55
pubmed: 22942255
Front Oncol. 2020 Aug 12;10:1415
pubmed: 32903519
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):939-948
pubmed: 31504670
Biochimie. 2017 Sep;140:66-72
pubmed: 28624527
Nat Genet. 2006 Jun;38 Suppl:S20-4
pubmed: 16736020
Mol Cancer. 2014 Jan 15;13:8
pubmed: 24423412
Bladder Cancer. 2016 Oct 27;2(4):473-474
pubmed: 28035330
Int J Mol Med. 2021 Feb;47(2):741-750
pubmed: 33416100
Cancer Cell Int. 2019 Feb 28;19:42
pubmed: 30858759
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3638-3648
pubmed: 31456425
Oncotarget. 2016 Nov 15;7(46):76250-76260
pubmed: 27788488
Mol Cancer. 2020 Mar 27;19(1):67
pubmed: 32220259
PeerJ. 2020 Dec 16;8:e10494
pubmed: 33362968
Tumour Biol. 2016 Jan;37(1):177-83
pubmed: 26586400
J Cell Biochem. 2018 Nov;119(11):9408-9418
pubmed: 30132983
J Mol Biol. 2010 Sep 24;402(3):491-509
pubmed: 20678503
Sci Rep. 2020 Jun 26;10(1):10418
pubmed: 32591615
Clin Transl Sci. 2015 Dec;8(6):668-75
pubmed: 26356996
Oncol Res. 2018 Jan 19;26(1):145-155
pubmed: 28337959
Nat Commun. 2016 May 05;7:11406
pubmed: 27147225
Nat Rev Urol. 2013 Jul;10(7):396-404
pubmed: 23712207
Zhonghua Gan Zang Bing Za Zhi. 2020 Nov 20;28(11):930-935
pubmed: 33256278
Transl Oncol. 2020 Feb;13(2):193-200
pubmed: 31869744
Cell Death Dis. 2020 Sep 10;11(9):733
pubmed: 32913183
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Mol Cancer Res. 2019 Jan;17(1):30-41
pubmed: 30213797
Exp Cell Res. 2018 Dec 15;373(1-2):188-197
pubmed: 30463687
Cancer Manag Res. 2020 Sep 28;12:9087-9096
pubmed: 33061603
Oncogene. 2020 Aug;39(35):5768-5781
pubmed: 32719439
Mucosal Immunol. 2016 Jul;9(4):960-73
pubmed: 26530135
Biochem Cell Biol. 2017 Oct;95(5):571-577
pubmed: 28521108
Biomed Pharmacother. 2018 Jan;97:511-517
pubmed: 29091902
Neoplasma. 2018 Sep 19;65(5):769-778
pubmed: 29940767
Oncotarget. 2015 Jun 30;6(18):16043-58
pubmed: 25965824
Biochem Biophys Res Commun. 2018 Sep 5;503(2):556-563
pubmed: 29807015
J Cell Mol Med. 2019 Dec;23(12):8114-8127
pubmed: 31599500
Int J Mol Med. 2019 Apr;43(4):1585-1596
pubmed: 30720059
Front Genet. 2020 Aug 14;11:892
pubmed: 32922436
J Biomed Nanotechnol. 2020 Jun 1;16(6):876-884
pubmed: 33187583
Medicine (Baltimore). 2020 Aug 28;99(35):e22045
pubmed: 32871962
Biomed Pharmacother. 2018 Sep;105:461-469
pubmed: 29883941
Clin Epigenetics. 2018 Apr 23;10:59
pubmed: 29713393
Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6119-6130
pubmed: 31364112
Sci Rep. 2016 Dec 06;6:38339
pubmed: 27922090
J Korean Assoc Oral Maxillofac Surg. 2020 Oct 31;46(5):341-347
pubmed: 33122459
Sci Rep. 2019 May 3;9(1):6882
pubmed: 31053727
Front Immunol. 2019 Sep 12;10:2170
pubmed: 31572380
Int J Cancer. 2011 Mar 15;128(6):1327-34
pubmed: 20473948
Pathol Res Pract. 2019 Nov;215(11):152667
pubmed: 31585814
Front Oncol. 2019 Aug 07;9:729
pubmed: 31448232
Cancer Biol Ther. 2018;19(11):1039-1056
pubmed: 30461333
Biomed Pharmacother. 2019 Apr;112:108743
pubmed: 30970529
Mol Biol Rep. 2020 Nov;47(11):8819-8830
pubmed: 33128684
Arthritis Res Ther. 2019 Dec 11;21(1):276
pubmed: 31829247
Oncotarget. 2017 Aug 3;8(40):68721-68729
pubmed: 28978151
Life Sci. 2020 Nov 15;261:118435
pubmed: 32950571
Biomark Med. 2018 Dec;12(12):1311-1321
pubmed: 30507304
Oncotarget. 2017 Jun 20;8(25):40832-40842
pubmed: 28388561
Cell Death Differ. 2010 Feb;17(2):215-20
pubmed: 19498445
Biomed Pharmacother. 2016 Dec;84:1189-1193
pubmed: 27788476
J Cell Mol Med. 2020 Aug;24(15):8545-8556
pubmed: 32596945
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Mol Cancer. 2015 Nov 14;14:194
pubmed: 26576778
Oncol Rep. 2017 Nov;38(5):2727-2734
pubmed: 29048677
Genome Biol. 2015 Jan 29;16:18
pubmed: 25723320
Mol Med Rep. 2015 Nov;12(5):6752-60
pubmed: 26323574
Nat Genet. 2016 Dec;48(12):1490-1499
pubmed: 27749842
Biochem Biophys Res Commun. 2019 Jan 1;508(1):210-216
pubmed: 30473219
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3390-3400
pubmed: 31081094
Exp Mol Pathol. 2020 Oct;116:104488
pubmed: 32622012
Int J Biochem Cell Biol. 2020 May;122:105702
pubmed: 32087328
Life Sci. 2020 Aug 15;255:117857
pubmed: 32470446
Avicenna J Med Biotechnol. 2018 Apr-Jun;10(2):98-104
pubmed: 29849986
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1094-F1102
pubmed: 30892932
BMC Bioinformatics. 2011 Jan 24;12:32
pubmed: 21261995
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3415-3422
pubmed: 29917193
Pathol Res Pract. 2020 Feb;216(2):152792
pubmed: 31899048
Am J Transl Res. 2018 Aug 15;10(8):2579-2589
pubmed: 30210694
Mol Carcinog. 2021 Feb;60(2):125-137
pubmed: 33382472
J Intern Med. 2019 Jan;285(1):102-114
pubmed: 30280445
Biosci Rep. 2019 Jul 10;39(7):
pubmed: 31221814
Oncotarget. 2016 May 3;7(18):26593-603
pubmed: 27058893
Mol Cancer. 2019 Aug 22;18(1):126
pubmed: 31438963
Arch Virol. 2021 Mar;166(3):755-766
pubmed: 33420627
Mol Ther Nucleic Acids. 2019 Jun 7;16:531-542
pubmed: 31071529
Oncol Rep. 2014 Apr;31(4):1509-16
pubmed: 24573597
FEBS Open Bio. 2021 Feb;11(2):529-540
pubmed: 33145996
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71
pubmed: 18362358
Tumour Biol. 2017 Feb;39(2):1010428317691678
pubmed: 28222670
Nat Rev Cancer. 2015 Jan;15(1):25-41
pubmed: 25533674
Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11804-11809
pubmed: 33275252
Neurourol Urodyn. 2019 Aug;38(6):1571-1578
pubmed: 31157926
Exp Ther Med. 2019 Sep;18(3):1601-1608
pubmed: 31410115
Medicine (Baltimore). 2020 Dec 4;99(49):e23163
pubmed: 33285691
Immunogenetics. 2021 Apr;73(2):155-161
pubmed: 33399935
PLoS One. 2014 Nov 17;9(11):e113050
pubmed: 25401928
Kaohsiung J Med Sci. 2018 Jun;34(6):335-340
pubmed: 29747777
Cancer Cell Int. 2020 Oct 12;20:502
pubmed: 33061854
Life Sci. 2020 Dec 1;262:118480
pubmed: 32980391
J Clin Invest. 2019 Dec 2;129(12):5518-5536
pubmed: 31710308
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7679-7687
pubmed: 30536310
Oncol Lett. 2021 Feb;21(2):91
pubmed: 33376524
Thorac Cancer. 2021 Feb;12(4):539-548
pubmed: 33372399
J Biol Regul Homeost Agents. 2020 Feb 28;34(1):
pubmed: 32107907
Med Sci Monit. 2019 Sep 27;25:7258-7271
pubmed: 31560680
PLoS One. 2010 Mar 12;5(3):e9685
pubmed: 20300190
Int J Oncol. 2013 Aug;43(2):548-60
pubmed: 23708087